Life sciences industry

Thought leadership from the IBM Institute of Business Value

The evolving promise of genomic medicine: How advanced technologies are transforming healthcare and life sciences

Updated 01 Jun 2014

A mix of influences - including innovation in biology and technology, market demand and consumerism - is furthering a genomic medicine evolution that crosses industries.

Learn more and download the executive report


Analytics across the ecosystem - A prescripion for optimizing healthcare outcomes

Updated 27 Sep 2013

To optimize patient, provider, payer and life sciences outcomes, organizations must drive analytics not just across the enterprise, but throughout the healthcare ecosystem.

Learn more and read the executive report


Trusting the science that drives your business: A systematic approach to verify scientific claims

Updated 30 Apr 2013

The time has come for an independent, systematic and unbiased process for auditing scientific claims to help increase consumer confidence in scientific outcomes, reduce risks and generate more value.

Learn more and read the executive report


Fade or flourish? Rethinking the role of life sciences companies in the healthcare ecosystem

Updated 22 Aug 2011

Facing business model challenges and dramatic changes in the healthcare ecosystem, today’s life sciences must rethink how they engage with the other stakeholders in the healthcare ecosystem.


The future of connected health devices: Liberating the Information Seeker

Updated 30 Mar 2011

Health device makers have a chance to capture a large, emerging market if they approach this opportunity with comprehensive, integrated solutions.


The wisdom of the cloud: Cloud computing in the life sciences industry

Updated 12 Nov 2010

Cloud computing in life sciences can facilitate innovation and help create new, more efficient business models.


Collaborative innovation: Partnering for success in Life Sciences

Updated 25 Oct 2010

The ability to tap new sources of innovation is becoming more important than ever, as declining R&D productivity, the "patent cliff" and intense generic competition all take their toll on Big Pharma.


Growth and collaboration: Embracing new challenges facing China's life sciences market

Updated 22 Apr 2010

China's essential drug list will create challenges and opportunities for China’s pharmaceutical companies, distributors and hospitals, and will trigger changes in how they operate.


Prescription for healthier growth: Shaping China's life sciences market

Updated 23 Jul 2009

Competitors in China’s life sciences market should prepare themselves for the market’s massive changes and continued growth by increasing their capabilities in three key areas: innovation; manufacturing quality; and sales, marketing and distribution.


The new biopharmaceutical blueprint: Aligning business and IT with service-oriented architecture

Updated 21 Apr 2009

Service-oriented architecture (SOA) can serve as the new blueprint for aligning business and IT.


Cultivating innovation beyond corporate walls: Alliances between the life sciences industry and academia

Updated 09 Feb 2009

Within an industry in need of the type of collaboration that gave rise to the biotech era, new models are emerging that can facilitate partnership between life sciences companies and academic institutions, diminish the sting of past failures and result in significant therapeutic advances.


A marriage of minds: Making biopharmaceutical collaborations work

Updated 19 Jan 2009

Fewer than half the respondents in the latest biopartnering survey jointly conducted by the IBM Institute for Business Value and Silico Research say that their alliances have met their expectations


Advancing the utility of imaging biomarkers: Insights from the second Imaging Biomarker Summit

Updated 19 Jan 2009

Imaging biomarkers hold great promise to assuage some of society’s costliest challenges, and technology can accelerate progress as the full ecosystem - including government, academia, BioPharma industry and imaging industry - contributes toward achieving this vision.


The evolving role of biomarkers: Focusing on patients from research to clinical practice

Updated 19 Jan 2009

The science of biomarker-enabled R&D is advancing quicker than general acceptance. To realize the full potential of biomarkers, the industry must take actions to increase the confidence of regulators, the medical community and the public at large.


Imperfect harmony: Alliances within the life sciences industry

Updated 09 Dec 2008

Partnerships are vital to large biopharmaceutical companies - and yet many lack the collaborative capabilities they need. This study outlines the characteristics biotechs and academics are looking for in a partner and suggests ways larger companies can become more attractive suitors.


The Enterprise of the Future: IBM Global CEO Study - Life Sciences Edition

Updated 11 Aug 2008

CEOs across the Life Sciences industry weigh in on the future of business.


In the interest of the patient: Convergence across the pharmaceutical and healthcare industries

Updated 12 Dec 2006

To make serious strides toward improving patient health, the pharmaceutical and healthcare industries need to marshall their collective data assets and collaborate more closely.


The eClinical equation: Part 2 – Bridging connections for innovation

Updated 25 Oct 2006

The pharmaceutical industry (Pharma) is at a critical point in its transition to a new model of drug development: making targeted medicines.


Pharma's new world view: Transforming R&D through emerging markets

Updated 30 Sep 2006

Pharma's new world view: Transforming R&D through emerging markets


Learning the biopartnering game: How to achieve more from your biotech alliance

Updated 14 Feb 2006

Recent advances in molecular science are expected to yield medical treatments targeted not just for individual ailments, but also for highly segmented patient groups. As they pursue this exciting vision, pharmaceutical and biotechnology (biotech) companies are actively engaging in alliances.


IBM Industries


  • IdeaWatch

    IdeaWatch Newsletter

    Sign up to receive monthly e-mail updates on recent papers from the IBM Institute for Business Value.